- Home
- VIPS vs CAI Comparison
VIPS vs CAI Comparison
Compare VIPS & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIPS
- CAI
- Stock Information
- Founded
- VIPS 2008
- CAI 2008
- Country
- VIPS China
- CAI United States
- Employees
- VIPS N/A
- CAI N/A
- Industry
- VIPS Catalog/Specialty Distribution
- CAI Medical Specialities
- Sector
- VIPS Consumer Discretionary
- CAI Health Care
- Exchange
- VIPS Nasdaq
- CAI Nasdaq
- Market Cap
- VIPS 7.8B
- CAI 8.3B
- IPO Year
- VIPS 2012
- CAI 2025
- Fundamental
- Price
- VIPS $15.11
- CAI $28.04
- Analyst Decision
- VIPS Buy
- CAI Strong Buy
- Analyst Count
- VIPS 7
- CAI 6
- Target Price
- VIPS $16.38
- CAI $32.33
- AVG Volume (30 Days)
- VIPS 2.6M
- CAI 542.5K
- Earning Date
- VIPS 08-19-2025
- CAI 01-01-0001
- Dividend Yield
- VIPS 3.17%
- CAI N/A
- EPS Growth
- VIPS N/A
- CAI N/A
- EPS
- VIPS 1.91
- CAI N/A
- Revenue
- VIPS $14,751,394,480.00
- CAI $452,498,000.00
- Revenue This Year
- VIPS $0.21
- CAI $44.16
- Revenue Next Year
- VIPS $1.92
- CAI $62.71
- P/E Ratio
- VIPS $7.91
- CAI N/A
- Revenue Growth
- VIPS N/A
- CAI 34.67
- 52 Week Low
- VIPS $11.50
- CAI $25.40
- 52 Week High
- VIPS $17.94
- CAI $33.41
- Technical
- Relative Strength Index (RSI)
- VIPS 45.74
- CAI N/A
- Support Level
- VIPS $14.95
- CAI N/A
- Resistance Level
- VIPS $16.66
- CAI N/A
- Average True Range (ATR)
- VIPS 0.38
- CAI 0.00
- MACD
- VIPS -0.11
- CAI 0.00
- Stochastic Oscillator
- VIPS 14.60
- CAI 0.00
About VIPS Vipshop Holdings Limited
Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts ranging from 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurements, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with over 29,000 global partners as of Dec. 31, 2023. As of March 31, 2024, Eric Ya Shen, chairman and CEO, has 63.1% voting rights and a 30.9% stake while Arthur Xiaobo Hong, vice chairman and COO, has a 17.6% stake. Leading Chinese social media firm and strategic shareholder Tencent also holds an 11.8% interest.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.